CANNAPHARMARX, INC. (CPMD) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K/A	10-K	10-K	10-K	10-K
Revenues	-6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Revenue growth							-100.0%
Cost of goods sold	-6.7	0.0	0.0	0.0	0.0	1.0	11.7	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	-1.0	-11.7	0.0
Gross margin	0.0%							89.9%
Selling, general and administrative [+]	2.1	3.1	1.1	0.3	0.0	0.3	4.2	1.0
Sales and marketing				0.3				0.2
General and administrative [+]	2.1	3.1	1.1	0.0	0.0	0.3	4.2	0.8
Wages and related expenses								0.2
General and administrative expenses	0.9	2.1	0.5	0.0	0.0	0.3	4.2	0.4
Professional fees	1.2	0.9	0.5					0.3
Rent expense	0.0	0.0	0.0
Other selling, general and administrative				0.3				0.2
Other operating expenses	0.6	1.4	8.8	0.6		-0.3	-4.2	1.1
EBITDA [+]	-2.6	-4.5	-9.9				-11.6	-2.0
EBITDA growth	-42.0%	-54.5%	994.4%	13568.1%	-99.3%	-91.4%	476.3%	2415.2%
EBITDA margin	39.2%							-5802.8%
Depreciation	0.0	0.0	0.0				0.0	0.0
EBITA	-2.6	-4.5	-9.9	-0.9	0.0	-1.0	-11.7	-2.0
EBITA margin	39.2%							-5811.5%
Amortization of intangibles		0.1	0.1
EBIT [+]	-2.6	-4.6	-10.1	-0.9	0.0	-1.0	-11.7	-2.0
EBIT growth	-43.6%	-53.9%	1008.7%	13568.1%	-99.3%	-91.4%	476.0%	2419.0%
EBIT margin	39.2%							-5811.5%
Non-recurring items [+]	0.4	9.8	5.9	0.0				1.9
Asset impairment		8.0
Legal settlement								1.9
Interest expense, net [+]	1.5	2.3	4.5			0.0	0.0	0.0
Interest expense	1.5	2.3	4.5			0.0	0.0	0.0
Interest income								0.0
Other income (expense), net [+]	-4.3	-3.1		-2.1		0.0	-0.1	0.0
Impairment of investments			7.1
Gain (loss) on sale of assets							-0.1
Gain (loss) on derivative instruments	3.2	-3.7
Other				-2.1		0.0
Pre-tax income	-8.8	-19.9	-20.5	-3.1	0.0	-1.0	-11.7	-4.0
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-8.8	-19.9	-20.5	-3.1	0.0	-1.0	-11.7	-4.0
Net margin	132.4%							-11428.7%

Basic EPS [+]	($0.12)	($0.49)	($0.66)	($0.17)	$0.00	($0.06)	($0.77)	($0.36)
Growth	-75.8%	-25.5%	280.8%	46543.2%	-99.3%	-92.7%	113.0%	807.8%
Diluted EPS [+]	($0.12)	($0.49)	($0.66)	($0.17)	$0.00	($0.06)	($0.77)	($0.36)
Growth	-75.8%	-25.5%	280.8%	46543.2%	-99.3%	-92.7%	113.0%	807.8%

Shares outstanding (basic) [+]	74.7	40.7	31.2	18.0	18.0	18.0	15.3	11.1
Growth	83.5%	30.6%	73.5%	0.0%	0.0%	17.1%	38.6%	364.2%
Shares outstanding (diluted) [+]	74.7	40.7	31.2	18.0	18.0	18.0	15.3	11.1
Growth	83.5%	30.6%	73.5%	0.0%	0.0%	17.1%	38.6%	364.2%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.